Application Nr Approved Date Route Status External Links
BLA761128 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Adakveo ® Is Indicated To Reduce The Frequency Of Vasoocclusive Crises (Vocs) In Adults And Pediatric Patients Aged 16 Years And Older With Sickle Cell Disease. Adakveo Is A Selectin Blocker Indicated To Reduce The Frequency Of Vasoocclusive Crises In Adults And Pediatric Patients Aged 16 Years And Older With Sickle Cell Disease.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Crizanlizumab

Comments